Atu027, a liposomal small interfering RNA formulation targeting protein kinase N3, inhibits cancer progression.
Aleku M, Schulz P, Keil O, Santel A, Schaeper U, Dieckhoff B, Janke O, Endruschat J, Durieux B, Röder N, Löffler K, Lange C, Fechtner M, Möpert K, Fisch G, Dames S, Arnold W, Jochims K, Giese K, Wiedenmann B, Scholz A, Kaufmann J.
Aleku M, et al. Among authors: fechtner m.
Cancer Res. 2008 Dec 1;68(23):9788-98. doi: 10.1158/0008-5472.CAN-08-2428.
Cancer Res. 2008.
PMID: 19047158